[go: up one dir, main page]

WO2008018118A1 - Composition containing nemagaritake and moisturizing agent, cellular stimulant, whitening agent and antioxidant - Google Patents

Composition containing nemagaritake and moisturizing agent, cellular stimulant, whitening agent and antioxidant Download PDF

Info

Publication number
WO2008018118A1
WO2008018118A1 PCT/JP2006/315612 JP2006315612W WO2008018118A1 WO 2008018118 A1 WO2008018118 A1 WO 2008018118A1 JP 2006315612 W JP2006315612 W JP 2006315612W WO 2008018118 A1 WO2008018118 A1 WO 2008018118A1
Authority
WO
WIPO (PCT)
Prior art keywords
extract
skin
antioxidant
negararidake
whitening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2006/315612
Other languages
French (fr)
Japanese (ja)
Inventor
Rika Negishi
Masaki Arashima
Sayaka Aramaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2008528670A priority Critical patent/JP5014343B2/en
Priority to PCT/JP2006/315612 priority patent/WO2008018118A1/en
Publication of WO2008018118A1 publication Critical patent/WO2008018118A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • Nemagari-dake-containing composition moisturizer, cell activator, whitening agent and antioxidant
  • the present invention relates to a nematode-containing composition, a humectant, a cell activator, a whitening agent and an antioxidant.
  • Patent Document 1 bamboo sasa plants, health foods and oral anti-tumor agents (Patent Document 2), anti-tumor agent compositions (Patent Document 2), anti-allergies that contain the extract as an active ingredient Agents (Patent Document 3) and antibacterial agents (Patent Document 4) are known.
  • Negararidake Puloaceae, Sara kurilensis
  • the extract is formulated as a keratinase inhibitor into a topical skin preparation (Patent Document 5), and into a cosmetic for hair.
  • Patent Document 6 a cosmetic liquid containing tishima zasa distillate obtained by fractionating a squeezed juice obtained by squeezing raw leaves and stems of chishima zasa (also known as nematode mushroom) (Patent Document 7).
  • Patent Document 1 Japanese Patent Application Laid-Open No. 2004-337151
  • Patent Document 2 Japanese Patent Application Laid-Open No. 2004-359698
  • Patent Document 3 Japanese Patent Laid-Open No. 9-278662
  • Patent Document 4 Japanese Patent Laid-Open No. 11-269020
  • Patent Document 5 Japanese Unexamined Patent Application Publication No. 2004-161621
  • Patent Document 6 Japanese Unexamined Patent Application Publication No. 2004-196731
  • Patent Document 7 Japanese Patent Application Laid-Open No. 2004-224750
  • the present invention is a composition derived from a natural product that can be widely applied in the field of external preparations for skin and foods and drinks, and can be applied to a humectant, a cell activator, a whitening agent, or an antioxidant.
  • the object is to provide a composition.
  • the present invention provides a nematode mushroom-containing composition having nematode mushroom as an active ingredient and having moisturizing, cell activation, whitening or antioxidant action.
  • Nemadaridake Pane Sasa, Scientific name: Sara kurilensis
  • it has excellent cell activation effect (anti-aging effect), collagen production promotion effect, antioxidant effect and melanin production inhibitory effect, and it is a moisturizer, cell activator, whitening agent or antioxidant.
  • the present inventors have found that it can be applied as an active ingredient and have completed the present invention.
  • Negararidake As an active ingredient in this way, a moisturizer, cell activator, whitening agent or antioxidant can be obtained.
  • a moisturizer for application to the skin a moisturizer for skin
  • a cell activator it can be used particularly effectively as a dermal fibroblast activator.
  • Negaridae functions as a tyrosinase activity inhibitor, and as a result, whitening effect is considered to be obtained.
  • Negaridae is also effective as a radical scavenger (radical scavenger), and it is thought that an antioxidant effect can be obtained by scavenging free radicals.
  • the present invention provides use (use method) of Negararidake as a moisturizer, cell activator, whitening agent or antioxidant.
  • Negararidake-containing composition that can be widely applied in the fields of external preparations for skin and foods and drinks, and can be applied as a moisturizer, cell activator, whitening agent or antioxidant.
  • This composition can be used as a moisturizer, cell activator, whitening agent or antioxidant having an excellent effect.
  • negararidake by adding negararidake to a composition such as an external preparation for skin and foods and drinks, it is possible to obtain an excellent effect in preventing and improving skin symptoms such as wrinkles, tarmi, skin firmness, spots, and scum.
  • Neakaridake (Sara kurilensis), which is a plant used as a raw material of the present invention, is a plant belonging to the genus Sasa of the family Gramineae. Nemagari-dake (Negakutake) is also known as Chishimazasa, Jitake, etc., and is grown in the Tohoku region and Hokkaido from the Sea of Japan in Honshu, Japan and north of Tottori Prefecture, and is available in these regions. .
  • Negararidake for extraction, it can be used after being pulverized as it is.
  • Nemagaritake may use any part of leaves, stems, roots, buds, flowers, etc., or a combination thereof, which may use the whole tissue for extraction. Since the above-described effects are more excellent, young shoots that preferably use shoots as nematode are more preferable.
  • the extraction it may be used as it is, but in consideration of the extraction efficiency, the amount of the extracted component, etc., the extraction can also be performed after processing such as shredding, drying, and pulverization.
  • an extraction method using immersion in an extraction solvent or using a supercritical fluid or a subcritical fluid can be applied.
  • the extraction force with stirring may be extracted after homogenizer or a mixer or the like is used to homogenize the raw material in the extraction solvent.
  • the extraction solvent is water; lower alcohols such as methanol, ethanol, propanol, isopropanol (referred to as alcohols having 6 or less carbon atoms; the same shall apply hereinafter); 1,3-butylene glycol, propylene glycol, dipropylene glycol, glycerin
  • Polyhydric alcohols such as: ethers such as ethyl ether and propyl ether; esters such as butyl acetate and ethyl acetate; ketones such as acetone and ethyl methyl ketone can be used, and one or two of them can be used. The above is selected and used.
  • the lower alcohols, polyhydric alcohols, ethers, esters and ketones correspond to polar organic solvents.
  • physiological saline physiological saline, phosphate buffer, phosphate buffered saline, or the like may also be used.
  • supercritical fluids and subcritical fluids such as ammonia may be used. That is, supercritical extraction and subcritical extraction may be performed using water, carbon dioxide, ethylene, propylene, ethanol, methanol, ammonia, and the like.
  • the extraction temperature is suitably from about 0 ° C to 5 ° C to below the boiling point of the extraction solvent.
  • the extraction time varies depending on the type of extraction solvent and the extraction temperature, but is preferably about 1 hour to 14 days.
  • the critical temperature and critical pressure are determined according to the medium used. For example, when the medium is carbon dioxide, the critical temperature is 31 ° C, the critical pressure is 7.3 MPa, when the medium is methanol, the critical temperature is 239 ° C, the critical pressure is 8. lMPa, and when the water is water, the critical temperature is 374 ° C, Critical pressure 22. Can be set to IMPa.
  • Particularly preferred as the extraction of the oyster mushroom is extraction with a lower alcohol aqueous solution (for example, a methanol aqueous solution or an ethanol aqueous solution, particularly an ethanol aqueous solution) at a normal temperature and normal pressure, and a high temperature (for example, 50 to 200 ° C, preferably 50 ( ⁇ 150 ° C, in particular 120 ° C) extraction with water under caloric pressure.
  • a lower alcohol aqueous solution for example, a methanol aqueous solution or an ethanol aqueous solution, particularly an ethanol aqueous solution
  • a high temperature for example, 50 to 200 ° C, preferably 50 ( ⁇ 150 ° C, in particular 120 ° C
  • the extract of Nemagari-dake with the above solvent can be used as it is.
  • the concentrated, dried product can be used again by dissolving it in water or a polar solvent. Further, it may be used after performing purification treatment such as decolorization, deodorization, desalting, etc. and fractionation treatment by column chromatography etc. within the range not impairing these physiological functions.
  • the above-mentioned extract of Negaridae, its processed products and fractions can be lyophilized after each processing and fractionation, and dissolved in a solvent before use.
  • An extract of Negaridae has an excellent moisturizing action, cell activation action, whitening action, and antioxidant action, and the moisturizing agent, cell activator, whitening agent, antioxidant, external preparation for skin, and food and drink Goods Can be used as
  • moisturizers, cell activators, whitening agents, and antioxidants which are made from the extract of Negararidake, can be used for hair that is not only applied to the skin but also can be taken orally. It can also be applied to pharmaceuticals.
  • a moisturizing agent containing an extract of Nemadaritake mushroom as an active ingredient exhibits an excellent moisturizing action on the skin and hair, and particularly has a high moisturizing effect on the skin.
  • a cell activator comprising an extract of Nemadaritake as an active ingredient exhibits an excellent activation effect on various cells, but particularly exhibits an excellent effect on dermal fibroblasts.
  • a whitening agent containing an extract of Nemagari-dake is effective for improving pigmentation symptoms such as stains and freckles, and is particularly effective for suppressing melanin production based on inhibition of tyrosinase activity. To do.
  • An antioxidant comprising an extract of Negaridae as an active ingredient exerts an excellent effect on the ability to exert an excellent antioxidant action, particularly a free radical scavenging action (action as a radical scavenger).
  • Negararidake extract in addition, by incorporating Negararidake extract into an external preparation for skin, it exhibits an excellent effect in preventing and improving skin symptoms such as wrinkles, tarmi, skin firmness, spots, Tasumi, dryness, and fine wrinkles.
  • a skin external preparation can be obtained, and can also be used as a skin external preparation for improving anti-aging or a skin external preparation for whitening.
  • the extract of Negararidake can also be used in foods and beverages for the purpose of beauty, health maintenance or nutritional supplementation.
  • Negararidake extract to be added to a skin external preparation as a moisturizer, cell activator, whitening agent, or antioxidant should be adjusted according to the type of skin external preparation, purpose of use, etc. but it is, in terms of effect and stability, 0001-50. it is preferably 0 wt% 0.1 of the total amount, more preferably 0. 001-25. 0 wt 0/0.
  • the dosage form of the external preparation for skin (humectant, cell activator, whitening agent, anti-oxidant agent, etc.) containing the extract of Negararidake is arbitrary, for example, soluble wrinkles such as lotion, It can be provided as a dispersion system such as an emulsification system such as cream or emulsion, or a calamine lotion. Furthermore, it can also be provided in various dosage forms such as aerosols, ointments, powders, granules filled with propellants.
  • the extract of Negaridae is used as a moisturizer, cell activator, whitening agent, antioxidant, etc.
  • oil preparations and moisturizing agents are usually included in pharmaceuticals, quasi-drugs, skin cosmetics, hair cosmetics and cleansing agents as needed.
  • Agents, powders, pigments, emulsifiers, solubilizers, detergents, ultraviolet absorbers, thickeners, drugs, fragrances, scabs, antibacterial / antifungal agents, alcohols and the like can be appropriately blended.
  • other cell activators, whitening agents, and antioxidants can be used in combination as long as the effects of the present invention are not impaired.
  • a sample obtained according to the production method described in Production Example 1 was used.
  • the evaluation was performed according to the following procedure. Normal human dermal fibroblasts were seeded in 96-well microphone mouthplates at 2.0 ⁇ 10 4 per well.
  • As the seeding medium Dulbecco's modified Eagle medium (DMEM) supplemented with 1% by weight of urine fetal serum (FBS) was used. After culturing for 24 hours, the medium was replaced with a sample prepared at each concentration in DMEM medium supplemented with 1% by mass FBS, and further cultured for 48 hours.
  • DMEM Dulbecco's modified Eagle medium
  • FBS urine fetal serum
  • the medium was replaced with a medium containing 400 ⁇ gZmL of 3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyltetrazolium bromide (MTT) and cultured for about 2 hours.
  • Formazan produced by the opening of the tetrazolium ring was extracted with 2-propanol.
  • the absorbance at 550 nm was measured with a microplate reader, and at the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated by the difference between the two measured values.
  • the evaluation results are shown in Table 1 as relative values with the cell activation effect in DMEM medium (blank) with 1% by mass FBS added without sample as 100.
  • a sample obtained according to the production method described in Production Example 1 was used.
  • the evaluation was performed according to the following procedure. Normal human dermal fibroblasts were seeded in 96-well microphone mouthplates at 2.0 ⁇ 10 4 per well.
  • the seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 0.5% by weight urchin fetal serum (FBS). After culturing for 24 hours, the medium was replaced with a sample prepared at various concentrations in DMEM medium supplemented with 1% by mass FBS, and further cultured for 24 hours.
  • DMEM Dulbecco's modified Eagle medium
  • FBS urchin fetal serum
  • type I collagen secreted into the culture supernatant was measured using an enzyme-linked immunosorbent assay (ELISA).
  • ELISA enzyme-linked immunosorbent assay
  • type I collagen in the culture supernatant is reacted with a rabbit anti-human type I collagen polyclonal antibody (CHEMICON) and then labeled with a peroxidase-labeled anti-rabbit IgG polyclonal antibody (HISTOFINE; -Chilei) as a secondary antibody. did.
  • the labeled peroxidase was reacted with 2,2,1-azinobis (3-ethylbenzothiazoline 6-sulfonic acid) diammonium salt (ABTS) and hydrogen peroxide, and then reacted with a microplate reader.
  • ABTS 2,2,1-azinobis (3-ethylbenzothiazoline 6-sulfonic acid) diammonium salt
  • the absorbance at 405 nm was measured. Furthermore, the amount of protein in each well was measured using the BCA Protein Assay Kit manufactured by PIERCE, and the amount of collagen produced per unit protein was determined.
  • the evaluation results are shown in Table 2 as relative values when the amount of collagen production per unit tank amount of the negative control is 100. In the table, ** indicates a significance probability of less than 1% (P ⁇ 0.01) with respect to significance P value in t-test.
  • B16 mouse melanoma (B16F0) cells were seeded at a density of 2000 cells per dish in a 35 mm dish.
  • the seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight urine fetal serum (FBS).
  • DMEM Dulbecco's modified Eagle medium
  • FBS urine fetal serum
  • the medium was changed to a medium adjusted to each concentration with 5% by mass FBS-added DMEM medium, and further cultured for 7 days. At this time, the sample is 5 masses with no additive.
  • / oFBS-added DMEM medium is a negative control (blank) and contains 5 mass of sodium lactate at a concentration of 50 mM.
  • / oFBS supplemented DMEM medium was used as a positive control.
  • the cells were collected using 0.25% trypsin, transferred to a 1.5 mL microtube, and centrifuged to obtain a cell precipitate.
  • the resulting precipitate was visually judged based on Table 4 with respect to its blackish state.
  • negative control was evaluated as 5 and positive control was evaluated as 1, which was used as an index for determining the sample-added medium.
  • the tissue solubilizer (trade name: Solvable) was added to the precipitate and boiled, then cooled to room temperature, and the absorbance at 500 nm was measured. Table 5 shows the determination results and the absorbance at 500 nm.
  • a formulation example of a skin external preparation skin external preparation applicable as a moisturizing agent, a cell activator, a whitening agent, an antioxidant, etc.
  • the amount of each component means mass%.
  • the oil phase components (1) to (6) are heated and dissolved at 80 ° C.
  • the aqueous phase components (7) to (10) are heated and dissolved at 80 ° C.
  • the oil phase component is added to this while stirring and emulsified uniformly with a homogenizer. After emulsification, start cooling and add (11) and (12) in order and mix uniformly.
  • Production method Dissolve (2) and (3) in (1). After dissolution, add (4) to (8) sequentially, and then stir well. Add (9) and mix uniformly.
  • the oil phase components (1) to (6) are heated and dissolved at 80 ° C.
  • the aqueous phase components (7) to (10) are heated and dissolved at 80 ° C.
  • the oil phase component is added to this while stirring and emulsified uniformly with a homogenizer. After emulsification, add (11), start cooling, add (12) at 40 ° C and mix uniformly.
  • Production method Mix the aqueous phase components (1) to (6) and dissolve at 75 ° C.
  • the oil phase components (7) to (14) are mixed and dissolved by heating at 75 ° C.
  • the mixture is uniformly emulsified with a homomixer. Start cooling after emulsification and cover (15) at 50 ° C. Cool to 40 ° C, add (16), and mix evenly.
  • Manufacturing method Add (1) to (2), stir uniformly, and then add (3). After stirring uniformly, add (5) previously dissolved in (4). After stirring uniformly, add (6) to (8) previously mixed and stir and mix uniformly.
  • Manufacturing method Dissolve (1) and (2) uniformly. Add (3) and (4) to this, and mix evenly.
  • Production method The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the water phase components (5) to (7) are heated and dissolved at 80 ° C, and mixed with the oil phase components uniformly. Start cooling, add (8) at 40 ° C, and mix uniformly.
  • the oil phase components (1) to (4) are mixed and dissolved by heating at 75 ° C.
  • the aqueous phase components (5) to (7) are mixed, dissolved by heating at 75 ° C, and the pigments (8) to (10) are added thereto and dispersed uniformly with a homomixer.
  • the oil phase component is added to the water phase component and emulsified with a homomixer. Start cooling after emulsification, add ingredients (11) and (12) at 40 ° C, and mix evenly.
  • the oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C.
  • (7)-(10) The aqueous phase components are mixed and dissolved by heating at 75 ° C, and the pigments (11) to (15) are added thereto and dispersed uniformly with a homomixer.
  • Manufacturing method Dissolve (5) and (6) in a part of (11) to 50 ° C, and gradually add to (4) heated to 50 ° C while stirring. After mixing this, disperse uniformly in (1) to (3), which is heated and dissolved at 70 ° C. To this, heat (7) to (10) in the remainder of (11) and dissolve at 70 ° C while stirring and emulsify with a homomixer. Start cooling after emulsification, add (12) at 40 ° C, and mix uniformly.
  • Manufacturing method (2) and (3) are mixed, heated to 80 ° C, and then dissolved in (1) heated to 80 ° C. After evenly dissolving, add (4) and (5) and start cooling with stirring. Cool to 40 ° C, add (6) and (7), and mix evenly.
  • Production method (1) to (4) are mixed uniformly.
  • the oil phase components (1) to (6) are mixed and heated and dissolved at 75 ° C.
  • the aqueous phase components (7) to (10) are heated and dissolved at 75 ° C., and the oil phase components are collected and emulsified with a homomixer. Cooling is started after emulsification, and the ingredients (11) and (12) are collected at 40 ° C and evenly mixed. Mix.
  • Production method Components (1) to (4) are mixed and homogenized.
  • Production method (1) to (5) are mixed uniformly.
  • a use test was conducted using a prescription containing Nemagaridake extract, and the effect of improving skin roughness due to drying was evaluated.
  • the nematode mushroom extract shown in Table 6 was blended in the emulsion formulation shown in Formulation Example 1, and the use test was conducted as Examples 5 and 6.
  • the nematode mushroom extract was replaced with purified water, and a use test was conducted simultaneously as Comparative Example 1.
  • a composition containing negaridae can be applied as a moisturizer, cell activator, whitening agent or antioxidant.
  • the This composition can be used as a moisturizer, cell activator, whitening agent or antioxidant having an excellent effect.
  • Negararidake to a composition such as an external preparation for skin and foods and drinks, it is possible to obtain an excellent effect in preventing and improving skin symptoms such as wrinkles, tarmi, skin firmness, spots, and kusumi.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

It is intended to provide a composition which contains, as the active ingredient, nemagaritake (Sasa kurilensis (Rupr) Makino) and has a moisturizing, cell stimulating, whitening or antioxidant effect. By adding it to compositions such as a skin preparation for external use, a food or a drink, it is possible to obtain various compositions exerting excellent effects of preventing or ameliorating skin conditions such as wrinkles, skin fitness, spots, dullness and so on.

Description

明 細 書  Specification

ネマガリダケ含有組成物、保湿剤、細胞賦活剤、美白剤及び抗酸化剤 技術分野  Nemagari-dake-containing composition, moisturizer, cell activator, whitening agent and antioxidant

[0001] 本発明は、ネマガリダケ含有組成物、保湿剤、細胞賦活剤、美白剤及び抗酸化剤 に関する。  [0001] The present invention relates to a nematode-containing composition, a humectant, a cell activator, a whitening agent and an antioxidant.

背景技術  Background art

[0002] 従来、シヮ、肌荒れ、タルミ、皮膚の弾性低下、しみやそばかすと!/、つた皮膚症状を 防止'改善するために、様々な保湿剤、細胞賦活剤、美白剤及び抗酸化剤の研究が なされてきた。しかしながら、優れた効果のある成分の開発は依然として待ち望まれ ている。  [0002] Conventionally, various moisturizers, cell activators, whitening agents and antioxidants have been used to prevent and improve skin wrinkles, rough skin, tarmi, reduced skin elasticity, stains and freckles! Has been studied. However, the development of highly effective ingredients is still awaited.

[0003] 一方、天然由来成分は、様々な薬理作用や美容効果を有することが知られ、これま でにも数多くの植物や菌類等が皮膚外用剤や飲食品等の分野に幅広く応用されて いる。しかし、天然由来成分の中には未だその効果が知られていないものも数多く存 在し、開発'研究の余地は充分にある。  [0003] On the other hand, naturally derived ingredients are known to have various pharmacological and cosmetic effects, and so far many plants and fungi have been widely applied in the fields of topical skin preparations and foods and drinks. Yes. However, there are many naturally-derived components whose effects are not yet known, and there is ample room for development research.

[0004] これまで、タケゃササ類の植物に関しては、その抽出物を有効成分とする健康食品 や経口用抗腫瘍剤 (特許文献 1)、抗腫瘍剤組成物 (特許文献 2)、抗アレルギー剤( 特許文献 3)及び抗菌剤 (特許文献 4)が知られて ヽる。 [0004] To date, regarding bamboo sasa plants, health foods and oral anti-tumor agents (Patent Document 1), anti-tumor agent compositions (Patent Document 2), anti-allergies that contain the extract as an active ingredient Agents (Patent Document 3) and antibacterial agents (Patent Document 4) are known.

[0005] ネマガリダケ (イネ科ササ属、 Sara kurilensis)に関しては、そのエキスを角化酵 素阻害剤として皮膚外用剤への配合 (特許文献 5)、及び毛髪用の化粧料への配合[0005] As for Negararidake (Poaceae, Sara kurilensis), the extract is formulated as a keratinase inhibitor into a topical skin preparation (Patent Document 5), and into a cosmetic for hair.

(特許文献 6)は知られている。また、チシマザサ (ネマガリダケの別名)の生の葉及び 茎を圧搾して得られる圧搾汁を分留して得られるチシマザサ留出液を含有する美容 液も知られて ヽる(特許文献 7)。 (Patent Document 6) is known. In addition, there is also known a cosmetic liquid containing tishima zasa distillate obtained by fractionating a squeezed juice obtained by squeezing raw leaves and stems of chishima zasa (also known as nematode mushroom) (Patent Document 7).

特許文献 1 :特開 2004— 337151号公報  Patent Document 1: Japanese Patent Application Laid-Open No. 2004-337151

特許文献 2:特開 2004— 359698号公報  Patent Document 2: Japanese Patent Application Laid-Open No. 2004-359698

特許文献 3:特開平 9 - 278662号公報  Patent Document 3: Japanese Patent Laid-Open No. 9-278662

特許文献 4:特開平 11― 269020号公報  Patent Document 4: Japanese Patent Laid-Open No. 11-269020

特許文献 5:特開 2004— 161621号公報 特許文献 6 :特開 2004— 196731号公報 Patent Document 5: Japanese Unexamined Patent Application Publication No. 2004-161621 Patent Document 6: Japanese Unexamined Patent Application Publication No. 2004-196731

特許文献 7:特開 2004 - 224750号公報  Patent Document 7: Japanese Patent Application Laid-Open No. 2004-224750

発明の開示  Disclosure of the invention

発明が解決しょうとする課題  Problems to be solved by the invention

[0006] 本発明は、皮膚外用剤や飲食品等の分野に幅広く応用が可能な、天然物由来の 組成物であって、保湿剤、細胞賦活剤、美白剤又は抗酸化剤に適用可能な組成物 を提供することを目的とする。 [0006] The present invention is a composition derived from a natural product that can be widely applied in the field of external preparations for skin and foods and drinks, and can be applied to a humectant, a cell activator, a whitening agent, or an antioxidant. The object is to provide a composition.

課題を解決するための手段  Means for solving the problem

[0007] 上記目的を達成するために、本発明は、ネマガリダケを有効成分とし、保湿、細胞 賦活、美白又は抗酸化作用を有するネマガリダケ含有組成物を提供する。  [0007] In order to achieve the above object, the present invention provides a nematode mushroom-containing composition having nematode mushroom as an active ingredient and having moisturizing, cell activation, whitening or antioxidant action.

[0008] 本発明者らは、種々の天然物につ!、て検討を行った結果、ネマガリダケ (イネ科サ サ属、学名: Sara kurilensis)、特にその柚出物は、従来全く知られていなカゝつた、 優れた細胞賦活効果 (抗老化効果)、コラーゲン産生促進効果、抗酸化効果及びメ ラニン生成抑制効果を有しており、保湿剤、細胞賦活剤、美白剤又は抗酸化剤の有 効成分として適用可能であることを見出し、本発明を完成するに至った。  [0008] As a result of investigations on various natural products, the present inventors have found that Nemadaridake (Poaceae Sasa, Scientific name: Sara kurilensis), in particular its exudate, has been completely known. It has excellent cell activation effect (anti-aging effect), collagen production promotion effect, antioxidant effect and melanin production inhibitory effect, and it is a moisturizer, cell activator, whitening agent or antioxidant. The present inventors have found that it can be applied as an active ingredient and have completed the present invention.

[0009] このようにネマガリダケを有効成分とすることで、保湿剤、細胞賦活剤、美白剤又は 抗酸化剤が得られるが、保湿剤としては皮膚に適用するための保湿剤 (皮膚用保湿 剤)の機能が特に優れており、細胞賦活剤としては真皮線維芽細胞賦活剤に特に有 効に用いることができる。また、ネマガリダケは、チロシナーゼ活性阻害剤として機能 し、その結果、美白効果が得られるものと考えられる。ネマガリダケはまた、ラジカルス キヤベンジャー (ラジカル捕捉剤)としても有効であり、フリーラジカルを捕捉すること で、抗酸化効果が得られるものと考えられる。  [0009] By using Negararidake as an active ingredient in this way, a moisturizer, cell activator, whitening agent or antioxidant can be obtained. As the moisturizer, a moisturizer for application to the skin (a moisturizer for skin) ) Is particularly excellent, and as a cell activator, it can be used particularly effectively as a dermal fibroblast activator. In addition, Negaridae functions as a tyrosinase activity inhibitor, and as a result, whitening effect is considered to be obtained. Negaridae is also effective as a radical scavenger (radical scavenger), and it is thought that an antioxidant effect can be obtained by scavenging free radicals.

[0010] 以上説明したように、本発明は、保湿剤、細胞賦活剤、美白剤又は抗酸化剤として のネマガリダケの使用(使用方法)を提供するものである。  [0010] As described above, the present invention provides use (use method) of Negararidake as a moisturizer, cell activator, whitening agent or antioxidant.

発明の効果  The invention's effect

[0011] 本発明によれば、皮膚外用剤や飲食品等の分野に幅広く応用が可能であり、保湿 剤、細胞賦活剤、美白剤又は抗酸化剤として適用可能なネマガリダケ含有組成物が 提供される。この組成物は、優れた効果を有する保湿剤、細胞賦活剤、美白剤又は 抗酸化剤として使用できる。また、ネマガリダケを皮膚外用剤や飲食品等の組成物に 配合することにより、シヮ、タルミ、肌のハリ、シミ、クスミ等の皮膚症状の防止や改善 に優れた効果を得ることができる。 [0011] According to the present invention, there is a Negararidake-containing composition that can be widely applied in the fields of external preparations for skin and foods and drinks, and can be applied as a moisturizer, cell activator, whitening agent or antioxidant. Provided. This composition can be used as a moisturizer, cell activator, whitening agent or antioxidant having an excellent effect. In addition, by adding negararidake to a composition such as an external preparation for skin and foods and drinks, it is possible to obtain an excellent effect in preventing and improving skin symptoms such as wrinkles, tarmi, skin firmness, spots, and scum.

発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION

[0012] 本発明の原料 して用いられる植物であるネマガリダケ(Sara kurilensis)は、ィ ネ科タケ亜科ササ属の植物である。ネマガリダケ (根曲竹)は、別名チシマザサ、ジダ ケ等とも呼ばれ、 日本国の本州、鳥取県以北の日本海側から東北地方、北海道に成 育しており、これらの地域で入手可能である。  [0012] Neakaridake (Sara kurilensis), which is a plant used as a raw material of the present invention, is a plant belonging to the genus Sasa of the family Gramineae. Nemagari-dake (Negakutake) is also known as Chishimazasa, Jitake, etc., and is grown in the Tohoku region and Hokkaido from the Sea of Japan in Honshu, Japan and north of Tottori Prefecture, and is available in these regions. .

[0013] 抽出用にネマガリダケを用いる場合は、そのまま粉砕して使用することできる。ネマ ガリダケは、その組織全体を抽出用に使用してもよぐ葉、茎、根、芽、花等のいずれ かの部位又はそれらの組み合わせを使用してもよい。上述した効果がより優れること から、ネマガリダケとして芽を用いることが好ましぐ幼芽がより好ましい。抽出の際は 、生のまま用いてもよいが、抽出効率や抽出される成分の量等を考慮すると、細切、 乾燥、粉砕等の処理を行った後に抽出を行うこともできる。  [0013] In the case of using Negararidake for extraction, it can be used after being pulverized as it is. Nemagaritake may use any part of leaves, stems, roots, buds, flowers, etc., or a combination thereof, which may use the whole tissue for extraction. Since the above-described effects are more excellent, young shoots that preferably use shoots as nematode are more preferable. In the extraction, it may be used as it is, but in consideration of the extraction efficiency, the amount of the extracted component, etc., the extraction can also be performed after processing such as shredding, drying, and pulverization.

[0014] 抽出方法としては、抽出溶媒に浸漬するか、超臨界流体や亜臨界流体を用いた抽 出方法が適用できる。抽出効率を上げるため、撹拌しながら抽出する力 抽出溶媒 中においてネマガリダケ原料をホモジナイザーやミキサー等によって均一化した後に 抽出してもよい。  [0014] As an extraction method, an extraction method using immersion in an extraction solvent or using a supercritical fluid or a subcritical fluid can be applied. In order to increase the extraction efficiency, the extraction force with stirring may be extracted after homogenizer or a mixer or the like is used to homogenize the raw material in the extraction solvent.

[0015] 抽出溶媒としては、水;メタノール、エタノール、プロパノール、イソプロパノール等 の低級アルコール(炭素数 6以下のアルコールを言う。以下同様); 1、 3—ブチレング リコール、プロピレングリコール、ジプロピレングリコール、グリセリン等の多価アルコー ル;ェチルエーテル、プロピルエーテル等のエーテル;酢酸ブチル、酢酸ェチル等の エステル;アセトン、ェチルメチルケトン等のケトン等の溶媒を用いることができ、これ らより 1種又は 2種以上を選択して用いる。なお、上記低級アルコール、多価アルコー ル、エーテル、エステル及びケトンは極性有機溶媒に該当する。  [0015] The extraction solvent is water; lower alcohols such as methanol, ethanol, propanol, isopropanol (referred to as alcohols having 6 or less carbon atoms; the same shall apply hereinafter); 1,3-butylene glycol, propylene glycol, dipropylene glycol, glycerin Polyhydric alcohols such as: ethers such as ethyl ether and propyl ether; esters such as butyl acetate and ethyl acetate; ketones such as acetone and ethyl methyl ketone can be used, and one or two of them can be used. The above is selected and used. The lower alcohols, polyhydric alcohols, ethers, esters and ketones correspond to polar organic solvents.

[0016] 抽出溶媒としてはまた、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等を用 いてもよい。さらに、水や二酸化炭素、エチレン、プロピレン、エタノール、メタノール、 アンモニア等の 1種又は 2種以上の超臨界流体や亜臨界流体を用いてもよい。すな わち、水、二酸化炭素、エチレン、プロピレン、エタノール、メタノール、アンモニア等 を用いて、ネマガリダケの超臨界抽出、亜臨界抽出を行ってもよい。 [0016] As the extraction solvent, physiological saline, phosphate buffer, phosphate buffered saline, or the like may also be used. In addition, water, carbon dioxide, ethylene, propylene, ethanol, methanol, One or more supercritical fluids and subcritical fluids such as ammonia may be used. That is, supercritical extraction and subcritical extraction may be performed using water, carbon dioxide, ethylene, propylene, ethanol, methanol, ammonia, and the like.

[0017] 抽出温度としては、 0°C〜5°C程度から抽出溶媒の沸点以下の温度とするのが適切 である。抽出時間は抽出溶媒の種類や抽出温度によって異なるが、 1時間〜 14日間 程度とするのが好ましい。  [0017] The extraction temperature is suitably from about 0 ° C to 5 ° C to below the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but is preferably about 1 hour to 14 days.

[0018] また、抽出は常温(室温、例えば 10〜40°C)、常圧(1気圧 =約1001^½)で行うこ とも、オートクレーブ等を用いて高温(例えば、 50〜200°C、好ましくは 50〜150°C) 高圧(例えば、 lOOkPa超 500kPa以下、好ましくは lOOkPa超 300kPa以下)で行う ことちでさる。  [0018] The extraction may be performed at normal temperature (room temperature, for example, 10 to 40 ° C) and normal pressure (1 atm = about 1001 ^ ½), or may be performed at a high temperature (for example, 50 to 200 ° C, using an autoclave). (Preferably 50 to 150 ° C.) It is performed at high pressure (for example, more than lOOkPa and less than 500 kPa, preferably more than lOOkPa and less than 300 kPa).

[0019] 超臨界抽出、亜臨界抽出を行う場合は、用いる媒体にしたがって、臨界温度、臨界 圧力を決定する。例えば、媒体が二酸化炭素の場合は、臨界温度 31°C、臨界圧力 7 . 3MPa、メタノールの場合は、臨界温度 239°C、臨界圧力 8. lMPa、水の場合は、 臨界温度 374°C、臨界圧力 22. IMPaに設定できる。  [0019] When performing supercritical extraction or subcritical extraction, the critical temperature and critical pressure are determined according to the medium used. For example, when the medium is carbon dioxide, the critical temperature is 31 ° C, the critical pressure is 7.3 MPa, when the medium is methanol, the critical temperature is 239 ° C, the critical pressure is 8. lMPa, and when the water is water, the critical temperature is 374 ° C, Critical pressure 22. Can be set to IMPa.

[0020] ネマガリダケの抽出として特に好ましいのは、常温常圧下における低級アルコール 水溶液 (例えば、メタノール水溶液又はエタノール水溶液、特にはエタノール水溶液 )での抽出、高温(例えば、 50〜200°C、好ましくは 50〜150°C、特には 120°C)カロ 圧下における水での抽出、である。このような抽出を行うことで、保湿剤、細胞賦活剤 、美白剤又は抗酸化剤としての機能に優れた抽出物を効果的且つ確実に得ることが できる。  [0020] Particularly preferred as the extraction of the oyster mushroom is extraction with a lower alcohol aqueous solution (for example, a methanol aqueous solution or an ethanol aqueous solution, particularly an ethanol aqueous solution) at a normal temperature and normal pressure, and a high temperature (for example, 50 to 200 ° C, preferably 50 (~ 150 ° C, in particular 120 ° C) extraction with water under caloric pressure. By performing such extraction, an extract having an excellent function as a moisturizer, cell activator, whitening agent or antioxidant can be obtained effectively and reliably.

[0021] ネマガリダケの上記溶媒による抽出物は、そのままでも使用することができる力 濃 縮、乾固した物を水や極性溶媒に再度溶解して力も使用することもできる。また、これ らの生理作用を損なわない範囲で脱色、脱臭、脱塩等の精製処理やカラムクロマトグ ラフィ一等による分画処理を行った後に用いてもよい。ネマガリダケの上記抽出物や その処理物及び分画物は、各処理及び分画後に凍結乾燥し、使用時に溶媒に溶解 して用いることちでさる。  [0021] The extract of Nemagari-dake with the above solvent can be used as it is. The concentrated, dried product can be used again by dissolving it in water or a polar solvent. Further, it may be used after performing purification treatment such as decolorization, deodorization, desalting, etc. and fractionation treatment by column chromatography etc. within the range not impairing these physiological functions. The above-mentioned extract of Negaridae, its processed products and fractions can be lyophilized after each processing and fractionation, and dissolved in a solvent before use.

[0022] ネマガリダケの抽出物は、優れた保湿作用、細胞賦活作用、美白作用、及び抗酸 化作用を有し、保湿剤、細胞賦活剤、美白剤、抗酸化剤、皮膚外用剤、及び飲食品 として利用することができる。また、ネマガリダケの抽出物を有効成分とする保湿剤、 細胞賦活剤、美白剤、抗酸化剤は、皮膚に外用するだけではなぐ毛髪に利用する ことや経口摂取も可能であり、食品、飲料、医薬品等にも応用することが可能である。 [0022] An extract of Negaridae has an excellent moisturizing action, cell activation action, whitening action, and antioxidant action, and the moisturizing agent, cell activator, whitening agent, antioxidant, external preparation for skin, and food and drink Goods Can be used as In addition, moisturizers, cell activators, whitening agents, and antioxidants, which are made from the extract of Negararidake, can be used for hair that is not only applied to the skin but also can be taken orally. It can also be applied to pharmaceuticals.

[0023] ネマガリダケの抽出物を有効成分とする保湿剤は、皮膚や毛髪に対して優れた保 湿作用を発揮し、特に皮膚に対する保湿効果が高い。  [0023] A moisturizing agent containing an extract of Nemadaritake mushroom as an active ingredient exhibits an excellent moisturizing action on the skin and hair, and particularly has a high moisturizing effect on the skin.

[0024] ネマガリダケの抽出物を有効成分とする細胞賦活剤は、種々の細胞に対して優れ た賦活作用を発揮するが、特に真皮線維芽細胞に対して優れた効果を発揮する。 [0024] A cell activator comprising an extract of Nemadaritake as an active ingredient exhibits an excellent activation effect on various cells, but particularly exhibits an excellent effect on dermal fibroblasts.

[0025] ネマガリダケの抽出物を有効成分とする美白剤は、シミ 'ソバカスといった色素沈着 症状の改善に効果を発揮し、特にチロシナーゼ活性阻害に基づくメラニンの産生抑 制に対して優れた効果を発揮する。 [0025] A whitening agent containing an extract of Nemagari-dake is effective for improving pigmentation symptoms such as stains and freckles, and is particularly effective for suppressing melanin production based on inhibition of tyrosinase activity. To do.

[0026] ネマガリダケの抽出物を有効成分とする抗酸化剤は、優れた抗酸化作用を発揮す る力 特にフリーラジカル消去作用(ラジカルスキヤベンジャーとしての作用)に優れ た効果を発揮する。 [0026] An antioxidant comprising an extract of Negaridae as an active ingredient exerts an excellent effect on the ability to exert an excellent antioxidant action, particularly a free radical scavenging action (action as a radical scavenger).

[0027] また、ネマガリダケの抽出物を皮膚外用剤に配合することにより、シヮ、タルミ、肌の ハリ、シミ、タスミ、乾燥、小じわ等の皮膚症状の防止'改善に優れた効果を発揮する 皮膚外用剤を得ることができ、老化防止改善用皮膚外用剤や美白用皮膚外用剤とし ても用いることができる。さらに、ネマガリダケの抽出物は、美容、健康維持、又は栄 養補給を目的とするような食品や飲料にも用いることもできる。  [0027] In addition, by incorporating Negararidake extract into an external preparation for skin, it exhibits an excellent effect in preventing and improving skin symptoms such as wrinkles, tarmi, skin firmness, spots, Tasumi, dryness, and fine wrinkles. A skin external preparation can be obtained, and can also be used as a skin external preparation for improving anti-aging or a skin external preparation for whitening. Furthermore, the extract of Negararidake can also be used in foods and beverages for the purpose of beauty, health maintenance or nutritional supplementation.

[0028] ネマガリダケの抽出物を、保湿剤、細胞賦活剤、美白剤、抗酸化剤としての皮膚外 用剤に配合する際の配合量は、皮膚外用剤の種類や使用目的等によって調整する ことができるが、効果や安定性等の点から、全量に対して 0. 0001-50. 0質量%が 好ましく、より好ましくは、 0. 001-25. 0質量0 /0である。 [0028] The amount of Negararidake extract to be added to a skin external preparation as a moisturizer, cell activator, whitening agent, or antioxidant should be adjusted according to the type of skin external preparation, purpose of use, etc. but it is, in terms of effect and stability, 0001-50. it is preferably 0 wt% 0.1 of the total amount, more preferably 0. 001-25. 0 wt 0/0.

[0029] ネマガリダケの抽出物を配合する皮膚外用剤 (保湿剤、細胞賦活剤、美白剤、抗酸 ィ匕剤等)の剤型は任意であり、例えば、ローション等の可溶ィ匕系、クリームや乳液等 の乳化系、カラミンローション等の分散系として提供することができる。さらに、噴射剤 と共に充填したエアゾール、軟膏剤、粉末、顆粒等の種々の剤型で提供することもで きる。  [0029] The dosage form of the external preparation for skin (humectant, cell activator, whitening agent, anti-oxidant agent, etc.) containing the extract of Negararidake is arbitrary, for example, soluble wrinkles such as lotion, It can be provided as a dispersion system such as an emulsification system such as cream or emulsion, or a calamine lotion. Furthermore, it can also be provided in various dosage forms such as aerosols, ointments, powders, granules filled with propellants.

[0030] なお、ネマガリダケの抽出物を保湿剤、細胞賦活剤、美白剤、抗酸化剤等として配 合する皮膚外用剤には、ネマガリダケの抽出物の他に、必要に応じて、通常医薬品 、医薬部外品、皮膚化粧料、毛髪用化粧料及び洗浄料に配合される、油性成分、保 湿剤、粉体、色素、乳化剤、可溶化剤、洗浄剤、紫外線吸収剤、増粘剤、薬剤、香 料、榭脂、防菌防黴剤、アルコール類等を適宜配合することができる。また、本発明 の効果を損なわない範囲において、他の細胞賦活剤、美白剤、抗酸化剤との併用も 可能である。 [0030] It should be noted that the extract of Negaridae is used as a moisturizer, cell activator, whitening agent, antioxidant, etc. In addition to Negararidake extract, oil preparations and moisturizing agents are usually included in pharmaceuticals, quasi-drugs, skin cosmetics, hair cosmetics and cleansing agents as needed. Agents, powders, pigments, emulsifiers, solubilizers, detergents, ultraviolet absorbers, thickeners, drugs, fragrances, scabs, antibacterial / antifungal agents, alcohols and the like can be appropriately blended. In addition, other cell activators, whitening agents, and antioxidants can be used in combination as long as the effects of the present invention are not impaired.

実施例  Example

[0031] 以下に、ネマガリダケの抽出物の製造例、各作用を評価するための試験、皮膚外 用剤や食品としての処方例、使用試験についてさらに詳細に説明するが、本発明は これによつて何ら限定されるものではな!/、。  [0031] In the following, the production example of the extract of the oyster mushroom, the test for evaluating each action, the prescription example as a skin external preparation and food, and the use test will be described in more detail. It is not limited at all!

[0032] 〔製造例 1〕  [Production Example 1]

ネマガリダケ幼芽の乾燥粉砕物に 20倍量の 50質量%エタノール水溶液を加え、 室温にて攪拌しながら 2時間抽出した。ろ過により不溶物を除き、抽出液を得た。抽 出液を減圧濃縮した後、凍結乾燥を行い、ネマガリダケの抽出物を得た。  20 times the amount of 50% by weight ethanol aqueous solution was added to dried pulverized larvae of Nemagari-dake and extracted for 2 hours while stirring at room temperature. Insoluble matter was removed by filtration to obtain an extract. The extract was concentrated under reduced pressure, and then freeze-dried to obtain an extract of Negaridae.

[0033] 〔製造例 2〕 [Production Example 2]

ネマガリダケ幼芽の乾燥粉砕物に 20倍量の精製水を加え、オートクレープを用い 1 20°Cにて 20分間加温し抽出した。高温を維持しながら吸引ろ過により不溶物を除き 、抽出液を得た。抽出液を減圧濃縮した後、凍結乾燥を行い、ネマガリダケの抽出物 を得た。  20 times the amount of purified water was added to the dried pulverized larvae of Nemagaridake, and the mixture was heated and extracted at 120 ° C for 20 minutes using an autoclave. While maintaining the high temperature, the insoluble matter was removed by suction filtration to obtain an extract. The extract was concentrated under reduced pressure, and then freeze-dried to obtain an extract of Negaridae.

[0034] 上記製造例によって得られたネマガリダケの抽出物を用いて各種評価試験を行つ た。  [0034] Various evaluation tests were conducted using the extract of the oyster mushroom obtained by the above production example.

[0035] 〔実施例 1〕 真皮細胞賦活作用の評価実験  [Example 1] Evaluation experiment of dermal cell activation action

この評価実験には、製造例 1に記載の製造方法に従って得られる試料を使用した。 評価は、以下の手順で行った。正常ヒト真皮線維芽細胞を 1ゥエル当たり 2. 0 X 104 個となるように 96ウェルマイク口プレートに播種した。播種培地には、ダルベッコ改変 イーグル培地(DMEM)に 1質量%のゥシ胎児血清 (FBS)を添カ卩したものを用いた 。 24時間培養後、培地を 1質量%FBS添加 DMEM培地にて各濃度に調製した試 料に交換し、さらに 48時間培養した。 [0036] 次いで、 3— (4, 5—ジメチルー 2—チアゾリル)—2, 5—ジフエ-ルテトラゾリゥムブ ロミド (MTT)を 400 μ gZmL含有する培地に交換して約 2時間培養し、テトラゾリゥ ム環の開環により生じるフオルマザンを 2—プロパノールにて抽出した。マイクロプレ 一トリーダーにて 550nmの吸光度を測定し、同時に濁度として 650nmにおける吸光 度を測定し、両測定値の差により細胞賦活作用を評価した。評価結果を、試料無添 加の 1質量%FBS添加 DMEM培地(ブランク)における細胞賦活作用を 100とした 相対値にて表 1に示す。なお、表中の * *は、 t検定における有意確率 P値に対し有 意確率 1%未満 (P< 0. 01)を表す。 In this evaluation experiment, a sample obtained according to the production method described in Production Example 1 was used. The evaluation was performed according to the following procedure. Normal human dermal fibroblasts were seeded in 96-well microphone mouthplates at 2.0 × 10 4 per well. As the seeding medium, Dulbecco's modified Eagle medium (DMEM) supplemented with 1% by weight of urine fetal serum (FBS) was used. After culturing for 24 hours, the medium was replaced with a sample prepared at each concentration in DMEM medium supplemented with 1% by mass FBS, and further cultured for 48 hours. [0036] Next, the medium was replaced with a medium containing 400 μgZmL of 3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyltetrazolium bromide (MTT) and cultured for about 2 hours. Formazan produced by the opening of the tetrazolium ring was extracted with 2-propanol. The absorbance at 550 nm was measured with a microplate reader, and at the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated by the difference between the two measured values. The evaluation results are shown in Table 1 as relative values with the cell activation effect in DMEM medium (blank) with 1% by mass FBS added without sample as 100. In the table, ** indicates a significance probability of less than 1% (P <0.01) with respect to the significance P value in the t test.

[0037] [表 1]  [0037] [Table 1]

真皮繊維芽細胞に対する細胞賦活作用  Cell activation on dermal fibroblasts

Figure imgf000008_0001
Figure imgf000008_0001

[0038] 表 1より明らかなように、ネマガリダケの抽出物を添加した培地では、有意な真皮線 維芽細胞賦活作用が認められた。特に、試料を 0. 25〜: L OmgZmL添加した場合 には、ブランクと比較して、危険率 1%未満で有意な真皮線維芽細胞賦活作用が認 められた。このことから、ネマガリダケの抽出物は、優れた真皮線維芽細胞賦活作用 を有することが明らかとなった。 [0038] As is clear from Table 1, a significant dermal fibroblast activation effect was observed in the medium supplemented with the extract of Negaridae. In particular, when 0.25 ~: L OmgZmL of the sample was added, significant dermal fibroblast activation was observed at a risk rate of less than 1% compared to the blank. From this, it was clarified that the extract of Nemadaritake has an excellent dermal fibroblast activation effect.

[0039] 〔実施例 2〕 I型コラーゲン産生促進作用の評価実験  [0039] [Example 2] Evaluation experiment of type I collagen production promoting action

この評価実験には、製造例 1に記載の製造方法に従って得られる試料を使用した。 評価は、以下の手順で行った。正常ヒト真皮線維芽細胞を 1ゥエル当たり 2. 0 X 104 個となるように 96ウェルマイク口プレートに播種した。播種培地には、ダルベッコ改変 イーグル培地(DMEM)に 0. 5質量%のゥシ胎児血清(FBS)を添カ卩したものを用い た。 24時間培養後、培地を 1質量%FBS添加 DMEM培地にて各濃度に調製した 試料に交換し、さらに 24時間培養した。このとき、ネガティブコントロール (ブランク)と して 0. 5質量0 /oFBS添カ卩 DMEM培地、ポジティブコントロールとして 50mgZmLの Lーァスコルビン酸リン酸エステルマグネシウム塩 (VCPMg)を含有する 0. 5質量0 /0 FBS添加 DMEM培地を用いた。 In this evaluation experiment, a sample obtained according to the production method described in Production Example 1 was used. The evaluation was performed according to the following procedure. Normal human dermal fibroblasts were seeded in 96-well microphone mouthplates at 2.0 × 10 4 per well. The seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 0.5% by weight urchin fetal serum (FBS). After culturing for 24 hours, the medium was replaced with a sample prepared at various concentrations in DMEM medium supplemented with 1% by mass FBS, and further cultured for 24 hours. In this case, 0.5 weight as a negative control (blank) 0 / oFBS添Ka卩DMEM medium, 0.5 mass containing the 50mgZmL as a positive control L Asukorubin acid phosphate ester magnesium salt (VCPMg) 0/0 DMEM medium supplemented with FBS was used.

[0040] 培養上清中に分泌された I型コラーゲンの量は酵素免疫吸着測定法 (ELISA)を 用いて測定した。まず、培養上清中の I型コラーゲンをゥサギ抗ヒト I型コラーゲンポリ クローナル抗体 (CHEMICON)と反応させ後、二次抗体としてペルォキシダーゼ標 識抗ゥサギ IgGポリクローナル抗体 (HISTOFINE ;-チレイ)を用いて標識した。次 に、標識したペルォキシダーゼに対し 2, 2,一アジノビス(3 ェチルベンゾチアゾリ ン 6—スルホン酸)ジアンモニア塩 (ABTS)及び過酸化水素を添カ卩し反応させた 後、マイクロプレートリーダーにて 405nmの吸光度を測定した。さらに、 PIERCE社 製 BCA Protein Assay Kitにて各ゥエルのタンパク量を測定し、単位タンパク量 当たりのコラーゲン産生量を求めた。評価結果を、ネガティブコントロールの単位タン ノ ク量当たりコラーゲン産生量を 100とした時の相対値にて表 2に示す。なお、表中 の * *は、 t検定における有意確率 P値に対し有意確率 1%未満 (P< 0. 01)を表す [0040] The amount of type I collagen secreted into the culture supernatant was measured using an enzyme-linked immunosorbent assay (ELISA). First, type I collagen in the culture supernatant is reacted with a rabbit anti-human type I collagen polyclonal antibody (CHEMICON) and then labeled with a peroxidase-labeled anti-rabbit IgG polyclonal antibody (HISTOFINE; -Chilei) as a secondary antibody. did. Next, the labeled peroxidase was reacted with 2,2,1-azinobis (3-ethylbenzothiazoline 6-sulfonic acid) diammonium salt (ABTS) and hydrogen peroxide, and then reacted with a microplate reader. The absorbance at 405 nm was measured. Furthermore, the amount of protein in each well was measured using the BCA Protein Assay Kit manufactured by PIERCE, and the amount of collagen produced per unit protein was determined. The evaluation results are shown in Table 2 as relative values when the amount of collagen production per unit tank amount of the negative control is 100. In the table, ** indicates a significance probability of less than 1% (P <0.01) with respect to significance P value in t-test.

[0041] [表 2] 真皮繊維芽細胞に対する I型コラーゲン産生促進作用 [0041] [Table 2] Promoting action of type I collagen production on dermal fibroblasts

Figure imgf000009_0001
Figure imgf000009_0001

[0042] 表 2より明らかなように、ネマガリダケの抽出物を添加した培地では、有意な真皮線 維芽細胞に対する I型コラーゲン産生促進作用が認められた。特に、試料を 0. 5〜1 . OmgZmL添加した場合には、ブランクと比較して、危険率 1%未満で有意な真皮 線維芽細胞賦活作用が認められた。このことから、ネマガリダケの抽出物は、優れた I 型コラーゲン産生促進作用を有することが明らかとなった。 [0042] As is apparent from Table 2, in the medium supplemented with the extract of Negaridae, a significant type I collagen production promoting effect on dermal fibroblasts was observed. In particular, when the sample was added at 0.5 to 1. OmgZmL, a significant dermal fibroblast activation effect was observed at a risk rate of less than 1% compared to the blank. From this, it has been clarified that the extract of Nemadaritake has an excellent type I collagen production promoting action.

[0043] 〔実施例 3〕 抗酸化作用(DPPHラジカル消去作用)の評価実験  [0043] [Example 3] Evaluation experiment of antioxidant action (DPPH radical scavenging action)

この評価実験には、製造例 1及び 2に記載の製造方法に従って得られる試料を使 用した。評価は、以下の手順で行った。試料を 50質量%エタノール水溶液を用いて 調整し、 96ウェルマイク口プレートに 100 L添カ卩した。次に、 0. 2mMl、 1—ジフエ -ルー 2—ピクリルヒドラジル(DPPH)のエタノール溶液を 96ウェルマイク口プレート に 100 /z L添加した。充分に混合後、室温にて暗所に 10分間静置した後、 516nm の吸光度を測定した。 試料が無添加のブランクの吸光度を (A)、試料を添加したと きの吸光度を (B)としたとき、下式によって求めた値をラジカル消去率とした。評価結 果を表 3に示した。 In this evaluation experiment, samples obtained according to the production methods described in Production Examples 1 and 2 were used. The evaluation was performed according to the following procedure. Using a 50% by weight ethanol aqueous solution Adjusted and added 100 L to a 96-well microphone opening plate. Next, 0.2 / mL of an ethanol solution of 1-diphe-lou 2-picrylhydrazyl (DPPH) was added to a 96-well microphone opening plate at 100 / zL. After thorough mixing, the mixture was allowed to stand in a dark place at room temperature for 10 minutes, and then the absorbance at 516 nm was measured. When the absorbance of the blank with no sample added was (A) and the absorbance when the sample was added was (B), the value obtained by the following formula was taken as the radical elimination rate. The evaluation results are shown in Table 3.

{ 1 - (B) / (A) } X 100 (%)  {1-(B) / (A)} X 100 (%)

[0044] [表 3] [0044] [Table 3]

抗酸化作用 (D P P Hラジカル除去能)  Antioxidant action (D P P H radical scavenging ability)

Figure imgf000010_0001
Figure imgf000010_0001

[0045] 表 3より明らかなように、ネマガリダケの抽出物はラジカル消去に基づく抗酸ィ匕作用 を有することが分力つた。  [0045] As is clear from Table 3, it was found that the extract of Negaridae has an anti-oxidative action based on radical scavenging.

[0046] 〔実施例 4〕 B16メラノーマを用いたメラニン産生抑制作用の評価実験  [Example 4] Evaluation experiment of inhibitory action on melanin production using B16 melanoma

この評価実験には、製造例 2に記載の製造方法に従って得られる試料を使用した。 評価は、以下の手順で行った。 B16マウスメラノーマ(B16F0)細胞を 35mmディッシ ュに 1ディッシュ当たり 2000個となるように播種した。播種培地には、ダルベッコ改変 イーグル培地(DMEM)に 5質量%のゥシ胎児血清 (FBS)を添カ卩したものを用いた 。 24時間培養後、 5質量%FBS添加 DMEM培地にて各濃度に調整した培地に交 換し、さらに 7日間培養した。このとき、試料が無添カ卩の 5質量。/ oFBS添加 DMEM培 地をネガティブコントロール (ブランク)とし、乳酸ナトリウムを 50mM濃度で含有する 5 質量。/ oFBS添カ卩 DMEM培地をポジティブコントロールとして用いた。  In this evaluation experiment, a sample obtained according to the production method described in Production Example 2 was used. The evaluation was performed according to the following procedure. B16 mouse melanoma (B16F0) cells were seeded at a density of 2000 cells per dish in a 35 mm dish. The seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight urine fetal serum (FBS). After culturing for 24 hours, the medium was changed to a medium adjusted to each concentration with 5% by mass FBS-added DMEM medium, and further cultured for 7 days. At this time, the sample is 5 masses with no additive. / oFBS-added DMEM medium is a negative control (blank) and contains 5 mass of sodium lactate at a concentration of 50 mM. / oFBS supplemented DMEM medium was used as a positive control.

[0047] 培養終了後、 0. 25%トリプシンを用いて細胞を回収し、 1. 5mLマイクロチューブ に移して遠心操作して細胞沈殿物を得た。得られた沈殿物は表 4を基にその黒ィ匕状 況を肉眼にて目視判定した。なお、このとき、ネガティブコントロールを評価 5、ポジテ イブコントロールを評価 1とし、試料添加培地の判定の指標とした。また、上記得られ た沈殿物に組織溶解剤(商品名: Solvable)を添加して煮沸した後、室温まで冷却し 、 500nm吸光度を測定した。表 5に判定の結果及び 500nm吸光度を示した。 [0047] After completion of the culture, the cells were collected using 0.25% trypsin, transferred to a 1.5 mL microtube, and centrifuged to obtain a cell precipitate. The resulting precipitate was visually judged based on Table 4 with respect to its blackish state. At this time, negative control was evaluated as 5 and positive control was evaluated as 1, which was used as an index for determining the sample-added medium. Also obtained above The tissue solubilizer (trade name: Solvable) was added to the precipitate and boiled, then cooled to room temperature, and the absorbance at 500 nm was measured. Table 5 shows the determination results and the absorbance at 500 nm.

[表 4]  [Table 4]

表 4 判定及び評価語  Table 4 Judgment and evaluation words

Figure imgf000011_0001
Figure imgf000011_0001

[0049] [表 5] [0049] [Table 5]

B 1 6メラノ一マを用いたメラニン生成抑制作用

Figure imgf000011_0002
Inhibition of melanin production using B 16 melanoma
Figure imgf000011_0002

[0050] 表 5より明らかなように、試料を lOOmgZmL添カ卩した培地を用いた場合、全く黒ィ匕 は認められず、ネマガリダケの抽出物は、優れたメラニン産生抑制作用を有すること が明らかとなった。  [0050] As can be seen from Table 5, when using a medium supplemented with lOOmgZmL of the sample, no black wrinkles were observed, and the nematode mushroom extract has an excellent inhibitory effect on melanin production. It became.

[0051] 次 、で、本発明に係るネマガリダケの抽出物を配合した皮膚外用剤 (保湿剤、細胞 賦活剤、美白剤、抗酸化剤等として適用できる皮膚外用剤)の処方例を示す。なお、 以下、特に明記しない限り、それぞれの成分の配合量は質量%を意味する。  [0051] Next, a formulation example of a skin external preparation (skin external preparation applicable as a moisturizing agent, a cell activator, a whitening agent, an antioxidant, etc.) formulated with the extract of the oyster mushroom according to the present invention will be shown. Hereinafter, unless otherwise specified, the amount of each component means mass%.

[0052] [処方例 1]乳液  [0052] [Prescription Example 1] Emulsion

(1)スクヮラン 10. 0  (1) Screen 10.0

(2)メチルフエ-ルポリシロキサン 4. 0  (2) Methylphenol polysiloxane 4.0

(3)水素添加パーム核油 0. 5  (3) Hydrogenated palm kernel oil 0.5

(4)水素添加大豆リン脂質 0. 1  (4) Hydrogenated soybean phospholipid 0.1

(5)モノステアリン酸ポリオキシエチレンソルビタン(20E. O. ) (6)モノステアリン酸ソルビタン 1. 0 (5) Polystearic acid polyoxyethylene sorbitan (20E. O.) (6) Sorbitan monostearate1.0

(7)グリセリン 4. 0  (7) Glycerin 4.0

(8)パラォキシ安息香酸メチル 0. 1  (8) Methyl paraoxybenzoate 0.1

(9)カノレボキシビニノレポリマー 0. 15  (9) Canoleboxyvininole polymer 0.15

(10)精製水 53. 85  (10) Purified water 53. 85

(11)アルギニン(1質量%水溶液) 20. 0  (11) Arginine (1 mass% aqueous solution) 20. 0

(12)ネマガリダケ抽出物 (製造例 1) 5. 0  (12) Negararidake extract (Production Example 1) 5.0

製法:(1)〜(6)の油相成分を 80°Cにて加熱溶解する。一方(7)〜( 10)の水相成 分を 80°Cにて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイ ザ一により均一に乳化する。乳化終了後、冷却を開始し、(11)と(12)を順次加え、 均一に混合する。  Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are heated and dissolved at 80 ° C. The oil phase component is added to this while stirring and emulsified uniformly with a homogenizer. After emulsification, start cooling and add (11) and (12) in order and mix uniformly.

[0053] [処方例 2]化粧水 [0053] [Prescription Example 2] lotion

(1)エタノール 15. 0  (1) Ethanol 15.0

(2)ポリオキシエチレン(40E. O. )硬化ヒマシ油  (2) Polyoxyethylene (40E. O.) hydrogenated castor oil

0. 3  0. 3

(3)香料 0. 1  (3) Fragrance 0. 1

(4)精製水 78. 38  (4) Purified water 78. 38

(5)クェン酸 0. 02  (5) Chenic acid 0.02

(6)クェン酸ナトリウム 0. 1  (6) Sodium quenate 0.1

(7)グリセリン 1. 0  (7) Glycerin 1.0

(8)ヒドロキシェチノレセノレロース 0. 1  (8) Hydroxyetinoresenorelose 0.1

(9)ネマガリダケ抽出物 (製造例 2) 5. 0  (9) Negararidake extract (Production Example 2) 5.0

製法:(1)に (2)及び (3)を溶解する。溶解後、(4)〜 (8)を順次添加した後、十分 に攪拌し、(9)を加え、均一に混合する。  Production method: Dissolve (2) and (3) in (1). After dissolution, add (4) to (8) sequentially, and then stir well. Add (9) and mix uniformly.

[0054] [処方例 3]クリーム [0054] [Prescription Example 3] Cream

(1)スクヮラン 10. 0  (1) Screen 10.0

(2)ステアリン酸 2. 0  (2) Stearic acid 2.0

(3)水素添加パーム核油 0. 5 (4)水素添加大豆リン脂質 0. 1 (3) Hydrogenated palm kernel oil 0.5 (4) Hydrogenated soybean phospholipid 0.1

(5)セタノール 3. 6  (5) Cetanol 3.6

(6)親油型モノステアリン酸グリセリン 2. 0  (6) Lipophilic glyceryl monostearate2.0

(7)グリセリン 10. 0  (7) Glycerin 10.0

(8)パラォキシ安息香酸メチル 0. 1  (8) Methyl paraoxybenzoate 0.1

(9)アルギニン(20質量%水溶液) 15. 0  (9) Arginine (20% by weight aqueous solution) 15. 0

(10)精製水 40. 7  (10) Purified water 40.7

(11)カルボキシビ二ルポリマー(1質量%水溶液)  (11) Carboxyvinyl polymer (1% by weight aqueous solution)

15. 0  15. 0

(12)ネマガリダケ抽出物 (製造例 1) 1. 0  (12) Negararidake extract (Production Example 1) 1.0

製法:(1)〜(6)の油相成分を 80°Cにて加熱溶解する。一方(7)〜( 10)の水相成 分を 80°Cにて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイ ザ一により均一に乳化する。乳化終了後、(11)を加え、冷却を開始し、 40°Cにて(1 2)を加え、均一に混合する。  Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are heated and dissolved at 80 ° C. The oil phase component is added to this while stirring and emulsified uniformly with a homogenizer. After emulsification, add (11), start cooling, add (12) at 40 ° C and mix uniformly.

[処方例 4]美容液 [Prescription Example 4] Essence

(1)精製水 27. 45  (1) Purified water 27. 45

(2)グリセリン 10. 0  (2) Glycerin 10.0

(3)ショ糖脂肪酸エステル 1. 3  (3) Sucrose fatty acid ester 1.3

(4)カルボキシビ二ルポリマー(1質量%水溶液)  (4) Carboxyvinyl polymer (1% by weight aqueous solution)

17. 5  17. 5

(5)アルギン酸ナトリウム(1質量%水溶液)  (5) Sodium alginate (1% by weight aqueous solution)

15. 0  15. 0

(6)モノラウリン酸ポリグリセリル 1. 0  (6) Polyglyceryl monolaurate 1.0

(7)マカデミアナッツ油脂肪酸フィトステリル  (7) Macadamia nut oil fatty acid phytosteryl

3. 0  3. 0

(8) N—ラウロイル L グルタミン酸ジ(フィトステリル  (8) N-lauroyl L di (phytosteryl) glutamate

2. 0  2. 0

(9)硬化パーム油 2. 0 (10)スクヮラン (ォリーブ由来) 1. 0 (9) Hardened palm oil 2.0 (10) Sukuran (Olive) 1.0

(11)ベへ-ルアルコール 0. 75  (11) Beheal alcohol 0.75

(12)ミッロゥ 1. 0  (12) Millow 1.0

(13)ホホバ油 1. 0  (13) Jojoba oil1.0

(14) 1, 3—ブチレングリコール 10. 0  (14) 1, 3-Butylene glycol 10. 0

(15) L—アルギニン(10質量%水溶液) 2. 0  (15) L-Arginine (10% by weight aqueous solution) 2.0

(16)ネマガリダケ抽出物 (製造例 2) 5. 0  (16) Negararidake extract (Production Example 2) 5.0

製法:(1)〜(6)の水相成分を混合し、 75°Cにて加熱溶解する。一方、(7)〜(14) の油相成分を混合し、 75°Cにて加熱溶解する。次いで、上記水相成分に油相成分 を添加して予備乳化を行った後、ホモミキサーにて均一に乳化する。乳化終了後に 冷却を開始し、 50°Cにて(15)をカ卩える。さらに 40°Cまで冷却し、(16)を加え、均一 に混合する。  Production method: Mix the aqueous phase components (1) to (6) and dissolve at 75 ° C. On the other hand, the oil phase components (7) to (14) are mixed and dissolved by heating at 75 ° C. Next, after preliminarily emulsifying by adding the oil phase component to the aqueous phase component, the mixture is uniformly emulsified with a homomixer. Start cooling after emulsification and cover (15) at 50 ° C. Cool to 40 ° C, add (16), and mix evenly.

[0056] [処方例 5]水性ジ ル [0056] [Prescription Example 5] Aqueous gel

(1)カノレボキシビニノレポリマー 0. 5  (1) Canoleboxyvininole polymer 0.5

(2)精製水 86. 7  (2) Purified water 86.7

(3)水酸ィ匕ナトリウム(10質量%水溶液) 0. 5  (3) Sodium hydroxide (10% by weight aqueous solution) 0.5

(4)エタノール 10. 0  (4) Ethanol 10.0

(5)パラォキシ安息香酸メチル 0. 1  (5) Methyl paraoxybenzoate 0.1

(6)香料 0. 1  (6) Fragrance 0. 1

(7)ネマガリダケ抽出物 (製造例 2) 2. 0  (7) Negararidake extract (Production Example 2) 2.0

(8)ポリオキシエチレン(60E. O. )硬化ヒマシ油  (8) Polyoxyethylene (60E. O.) hydrogenated castor oil

0. 1  0. 1

製法:(1)を (2)に加え、均一に攪拌した後、(3)を加える。均一に攪拌した後、(4) に予め溶解した(5)を加える。均一に攪拌した後、予め混合しておいた(6)〜(8)を 加え、均一に攪拌混合する。  Manufacturing method: Add (1) to (2), stir uniformly, and then add (3). After stirring uniformly, add (5) previously dissolved in (4). After stirring uniformly, add (6) to (8) previously mixed and stir and mix uniformly.

[0057] [処方例 6]クレンジング料 [0057] [Prescription Example 6] Cleansing Fee

(1)スクヮラン 81. 0  (1) Sukuran 81.0

(2)イソステアリン酸ポリオキシエチレングリセリル (3)精製水 3. 0 (2) Polyoxyethylene glyceryl isostearate (3) Purified water 3.0

(4)ネマガリダケ抽出物 (製造例 1) 1. 0  (4) Negararidake extract (Production Example 1) 1.0

製法:(1)と (2)を均一に溶解する。これに、(3)と (4)を順次加え、均一に混合する  Manufacturing method: Dissolve (1) and (2) uniformly. Add (3) and (4) to this, and mix evenly.

[0058] [処方例 7]洗顔フォーム [0058] [Prescription Example 7] Face-wash form

(1)ステアリン酸 16. 0  (1) Stearic acid 16.0

(2)ミリスチン酸 16. 0  (2) Myristic acid 16.0

(3)親油型モノステアリン酸グリセリン 2. 0  (3) Lipophilic glyceryl monostearate2.0

(4)グリセリン 20. 0  (4) Glycerin 20.0

(5)水酸ィ匕ナトリウム 7. 5  (5) Sodium hydroxide 7.5

(6)ヤシ油脂肪酸アミドプロピルべタイン 1. 0  (6) Palm oil fatty acid amidopropyl betaine 1.0

(7)精製水 36. 5  (7) Purified water 36.5

(8)ネマガリダケ抽出物 (製造例 2) 1. 0  (8) Negararidake extract (Production Example 2) 1.0

製法:(1)〜(4)の油相成分を 80°Cにて加熱溶解する。一方(5)〜(7)の水相成分 を 80°Cにて加熱溶解し、油相成分と均一に混合撹拌する。冷却を開始し、 40°Cにて (8)を加え、均一に混合する。  Production method: The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the water phase components (5) to (7) are heated and dissolved at 80 ° C, and mixed with the oil phase components uniformly. Start cooling, add (8) at 40 ° C, and mix uniformly.

[0059] [処方例 8]メイクアップベースクリーム [0059] [Prescription Example 8] Make-up base cream

(1)スクヮラン 10. 0  (1) Screen 10.0

(2)セタノール 2. 0  (2) Cetanol 2.0

(3)グリセリントリ— 2—ェチルへキサン酸エステル  (3) Glycerol tri-2-ethylhexanoate

2. 5  twenty five

(4)親油型モノステアリン酸グリセリル 1. 0  (4) Lipophilic glyceryl monostearate 1.0

(5)プロピレングリコール 11. 0  (5) Propylene glycol 11.0

(6)ショ糖脂肪酸エステル 1. 3  (6) Sucrose fatty acid ester 1.3

(7)精製水 69. 4  (7) Purified water 69.4

(8)酸化チタン 1. 0  (8) Titanium oxide 1.0

(9)ベンガラ 0. 1 (10)黄酸化鉄 0. 4 (9) Bengala 0.1 (10) Yellow iron oxide 0.4

(11)香料 0. 1  (11) Fragrance 0. 1

(12)ネマガリダケ抽出物 (製造例 1) 1. 2  (12) Negararidake extract (Production Example 1) 1.2

製法:(1)〜(4)の油相成分を混合し、 75°Cにて加熱溶解する。一方、(5)〜(7) の水相成分を混合し、 75°Cにて加熱溶解し、これに(8)〜(10)の顔料を加え、ホモ ミキサーにて均一に分散させる。この水相成分に前記油相成分を加え、ホモミキサー にて乳化する。乳化終了後に冷却を開始し、 40°Cにて(11)と(12)の成分を加え、 均一に混合する。  Manufacturing method: The oil phase components (1) to (4) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (5) to (7) are mixed, dissolved by heating at 75 ° C, and the pigments (8) to (10) are added thereto and dispersed uniformly with a homomixer. The oil phase component is added to the water phase component and emulsified with a homomixer. Start cooling after emulsification, add ingredients (11) and (12) at 40 ° C, and mix evenly.

処方例 9]乳液状ファンデーション  Formulation Example 9] Milk Foundation

1)メチノレポリシロキサン 2. 0  1) Methylenopolysiloxane 2.0

2)スクヮラン 5. 0  2) Screening 5.0

3)ミリスチン酸オタチルドデシル 5. 0  3) Otachidodecyl myristate 5.0

4)セタノーノレ 1. 0  4) Cetanore 1.0

5)ポリオキシエチレンソルビタン(20E. O. )モノステアリン酸エステル  5) Polyoxyethylene sorbitan (20E. O.) monostearate

1. 3  13

6)モノステアリン酸ソルビタン 0. 7  6) Sorbitan monostearate 0.7

7) 1, 3—ブチレングリコーノレ 8. 0  7) 1,3-Butyleneglycolanol 8.0

8)キサンタンガム 0. 1  8) Xanthan gum 0.1

9)パラォキシ安息香酸メチル 0. 1  9) Methyl paraoxybenzoate 0.1

10)精製水 57. 4  10) Purified water 57.4

11)酸化チタン 9. 0  11) Titanium oxide 9.0

12)タルク 7. 4  12) Talc 7.4

13)ベンガラ 0. 5  13) Bengala 0.5

14)黄酸化鉄 1. 1  14) Yellow iron oxide 1.1

15)黒酸化鉄 0. 1  15) Black iron oxide 0.1

16)香料 0. 1  16) Fragrance 0. 1

17)ネマガリダケ抽出物 (製造例 2) 1. 0  17) Negararidake extract (Production Example 2) 1.0

製法:(1)〜(6)の油相成分を混合し、 75°Cにて加熱溶解する。一方、(7)〜(10) の水相成分を混合し、 75°Cにて加熱溶解し、これに(11)〜(15)の顔料を加え、ホ モミキサーにて均一に分散する。油相成分を加え、乳化を行う。乳化終了後に冷却 を開始し、 40°Cにて(16)と(17)の成分を順次加え、均一に混合する。 Manufacturing method: The oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, (7)-(10) The aqueous phase components are mixed and dissolved by heating at 75 ° C, and the pigments (11) to (15) are added thereto and dispersed uniformly with a homomixer. Add oil phase ingredients and emulsify. Cooling is started after emulsification, and components (16) and (17) are added sequentially at 40 ° C and mixed uniformly.

[0061] [処方例 10]油中水型ェモリエントクリーム [0061] [Prescription Example 10] Water-in-oil emollient cream

(1)流動パラフィン 30. 0  (1) Liquid paraffin 30. 0

(2)マイクロクリスタリンワックス 2. 0  (2) Microcrystalline wax 2.0

(3)ワセリン 5. 0  (3) Vaseline 5.0

(4)ジグリセリンォレイン酸エステル 5. 0  (4) Diglycerinoleate 5.0

(5)塩ィ匕ナトリウム 1. 3  (5) Sodium salt sodium 1.3

(6)塩ィ匕カリウム 0. 1  (6) Potassium salt 0.1

(7)プロピレングリコーノレ 3. 0  (7) Propylene glycolate 3.0

(8) 1, 3—ブチレングリコーノレ 5. 0  (8) 1,3-Butyleneglycolanol 5.0

(9)パラォキシ安息香酸メチル 0. 1  (9) Methyl paraoxybenzoate 0.1

(10)ネマガリダケ抽出物 (製造例 2) 1. 0  (10) Negararidake extract (Production Example 2) 1.0

(11)精製水 47. 4  (11) Purified water 47.4

(12)香料 0. 1  (12) Fragrance 0. 1

製法:(5)と(6)を(11)の一部に溶解して 50°Cとし、 50°Cに加熱した (4)に撹拌し ながら徐々に加える。これを混合した後、 70°Cにて加熱溶解した(1)〜(3)に均一に 分散する。これに(7)〜(10)を(11)の残部に 70°Cにて加熱溶解したものを撹拌し ながらカ卩え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、 40°Cにて(12 )を加え、均一に混合する。  Manufacturing method: Dissolve (5) and (6) in a part of (11) to 50 ° C, and gradually add to (4) heated to 50 ° C while stirring. After mixing this, disperse uniformly in (1) to (3), which is heated and dissolved at 70 ° C. To this, heat (7) to (10) in the remainder of (11) and dissolve at 70 ° C while stirring and emulsify with a homomixer. Start cooling after emulsification, add (12) at 40 ° C, and mix uniformly.

[0062] [処方例 11]パック  [0062] [Prescription Example 11] Pack

(1)精製水 58. 9  (1) Purified water 58.9

(2)ポジビュルアルコール 12. 0  (2) Posibulal alcohol 12.0

(3)エタノール 17. 0  (3) Ethanol 17.0

(4)グリセリン 5. 0  (4) Glycerin 5.0

(5)ポリエチレングリコール(平均分子量 1000)  (5) Polyethylene glycol (average molecular weight 1000)

2. 0 (6)ネマガリダケ抽出物 (製造例 1) 5. 0 2. 0 (6) Negararidake extract (Production Example 1) 5.0

(7)香料 0. 1  (7) Fragrance 0. 1

製法:(2)と(3)を混合し、 80°Cに加温した後、 80°Cに加温した(1)に溶解する。均 一に溶解した後、(4)と(5)を加え、攪拌しながら冷却を開始する。 40°Cまで冷却し、 (6)と(7)を加え、均一に混合する。  Manufacturing method: (2) and (3) are mixed, heated to 80 ° C, and then dissolved in (1) heated to 80 ° C. After evenly dissolving, add (4) and (5) and start cooling with stirring. Cool to 40 ° C, add (6) and (7), and mix evenly.

[0063] [処方例 12]入浴剤 [0063] [Prescription Example 12] bath agent

(1)香料 0. 3  (1) Fragrance 0.3

(2)ネマガリダケ抽出物 (製造例 2) 1. 0  (2) Negararidake extract (Production Example 2) 1.0

(3)炭酸水素ナトリウム 50. 0  (3) Sodium bicarbonate 50. 0

(4)硫酸ナトリウム 48. 7  (4) Sodium sulfate 48.7

製法:(1)〜(4)を均一に混合する。  Production method: (1) to (4) are mixed uniformly.

[0064] [処方例 13]ヘアーワックス  [0064] [Prescription Example 13] Hair wax

(1)ステアリン酸 3. 0  (1) Stearic acid 3.0

(2)マイクロクリスタリンワックス 2. 0  (2) Microcrystalline wax 2.0

(3)セチルアルコール 3. 0  (3) Cetyl alcohol 3.0

(4)高重合メチルポリシロキサン 2. 0  (4) Highly polymerized methylpolysiloxane 2.0

(5)メチノレポリシロキサン 5. 0  (5) Methylenopolysiloxane 5.0

(6)ポリ(ォキシエチレン ·ォキシプロピレン)メチルポリシロキサン共重合体  (6) Poly (oxyethylene / oxypropylene) methylpolysiloxane copolymer

1. 0  Ten

(7)パラォキシ安息香酸メチル 0. 1  (7) Methyl paraoxybenzoate 0.1

(8) 1, 3—ブチレングリコール 7. 5  (8) 1,3-Butylene glycol 7.5

(9)アルギニン 0. 7  (9) Arginine 0.7

(10)精製水 73. 6  (10) Purified water 73.6

(11)ネマガリダケ抽出物 (製造例 2) 2. 0  (11) Negararidake extract (Production Example 2) 2.0

(12)香料 0. 1  (12) Fragrance 0. 1

製法:(1)〜(6)の油相成分を混合し、 75°Cにて加熱溶解後する。一方、(7)〜(1 0)の水相成分を 75°Cにて加熱溶解し、前記油相成分をカ卩え、ホモミキサーにて乳 化する。乳化終了後に冷却を開始し、 40°Cにて(11)と(12)の成分をカ卩え、均一に 混合する。 Production method: The oil phase components (1) to (6) are mixed and heated and dissolved at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are heated and dissolved at 75 ° C., and the oil phase components are collected and emulsified with a homomixer. Cooling is started after emulsification, and the ingredients (11) and (12) are collected at 40 ° C and evenly mixed. Mix.

[0065] [処方例 14]ヘアートニック  [0065] [Prescription Example 14] Hair art nick

(1)エタノール 50. 0  (1) Ethanol 50.0

(2)精製水 48. 9  (2) Purified water 48.9

(3)ネマガリダケ抽出物 (製造例 1) 1. 0  (3) Negararidake extract (Production Example 1) 1.0

(4)香料 0. 1  (4) Fragrance 0.1

製法:(1)〜(4)の成分を混合、均一化する。  Production method: Components (1) to (4) are mixed and homogenized.

[0066] [処方例 15]飲料  [0066] [Prescription Example 15] Beverage

(1)ネマガリダケ抽出物 (製造例 2) 8. 0  (1) Negararidake extract (Production Example 2) 8.0

(2)エリスリトール 1. 0  (2) Erythritol 1.0

(3)クェン酸 0. 1  (3) Chenic acid 0.1

(4)ステビア 0. 01  (4) Stevia 0. 01

(5)精製水 90. 89  (5) Purified water 90. 89

製法:(1)〜(5)を均一に混合する。  Production method: (1) to (5) are mixed uniformly.

[0067] 〔実施例 5、 6及び比較例 1〕 使用試験  [0067] [Examples 5 and 6 and Comparative Example 1] Usage test

ネマガリダケ抽出物を配合した処方を用いて使用試験を行い、乾燥による肌荒れ について改善効果を評価した。その際、処方例 1に示した乳液の処方に表 6に記載 するネマガリダケ抽出物をそれぞれ配合し、実施例 5及び 6として使用試験を行った 。また、ネマガリダケ抽出物を精製水に代替し、比較例 1として同時に使用試験を行 つた o  A use test was conducted using a prescription containing Nemagaridake extract, and the effect of improving skin roughness due to drying was evaluated. At that time, the nematode mushroom extract shown in Table 6 was blended in the emulsion formulation shown in Formulation Example 1, and the use test was conducted as Examples 5 and 6. In addition, the nematode mushroom extract was replaced with purified water, and a use test was conducted simultaneously as Comparative Example 1.

[0068] [表 6]  [0068] [Table 6]

Figure imgf000019_0001
Figure imgf000019_0001

各試料について、肌荒れ症状が顕著に認められる 30〜50才代の乾燥肌の女性パ ネラー 20名をそれぞれ一群とし、ブラインドにて 1週間使用させ、使用前後の皮膚状 態の変化を観察して評価した。皮膚症状の指標として、乾燥による肌荒れについて、 「改善」、「やや改善」、「変化なし」の三段階で評価し、表 7に各評価を得たパネラー 数にて示した。 For each sample, 20 female panelists with dry skin in their 30s to 50s who have markedly rough skin symptoms are grouped together and used blindly for 1 week to observe changes in skin condition before and after use. evaluated. As an indicator of skin symptoms, skin roughness due to dryness was evaluated in three stages: “Improved”, “Slightly improved”, and “No change”. Shown in number.

[0070] [表 7] [0070] [Table 7]

Figure imgf000020_0001
Figure imgf000020_0001

[0071] 表 7より、ネマガリダケ抽出物を含有しない比較例使用群においては、 8割のパネラ 一に改善は認められな力つたが、ネマガリダケ抽出物を配合した実施例使用群にお いては、 6割以上のパネラーに明確な肌荒れの改善が認められた。このことから、ネ マガリダケ抽出物は優れた保湿効果を有することが明らかとなった。  [0071] From Table 7, in the comparative example use group that does not contain the nematode mushroom extract, 80% of the panelists did not improve, but in the example use group containing the nematode mushroom extract, Over 60% of panelists showed clear improvement in rough skin. From this, it has been clarified that the extract of the oyster mushroom has an excellent moisturizing effect.

産業上の利用可能性  Industrial applicability

[0072] 本発明によれば、皮膚外用剤や飲食品等の分野に幅広く応用が可能であり、保湿 剤、細胞賦活剤、美白剤又は抗酸化剤として適用可能なネマガリダケ含有組成物が 提供される。この組成物は、優れた効果を有する保湿剤、細胞賦活剤、美白剤又は 抗酸化剤として使用できる。また、ネマガリダケを皮膚外用剤や飲食品等の組成物に 配合することにより、シヮ、タルミ、肌のハリ、シミ、クスミ等の皮膚症状の防止や改善 に優れた効果を得ることができる。 [0072] According to the present invention, it is possible to widely apply to the field of external preparations for skin, foods and drinks, etc., and a composition containing negaridae can be applied as a moisturizer, cell activator, whitening agent or antioxidant. The This composition can be used as a moisturizer, cell activator, whitening agent or antioxidant having an excellent effect. In addition, by adding Negararidake to a composition such as an external preparation for skin and foods and drinks, it is possible to obtain an excellent effect in preventing and improving skin symptoms such as wrinkles, tarmi, skin firmness, spots, and kusumi.

Claims

請求の範囲 The scope of the claims [1] ネマガリダケを有効成分とし、保湿、細胞賦活、美白又は抗酸化作用を有するネマガ リダケ含有組成物。  [1] A composition containing nematode mushrooms containing nematode mushroom as an active ingredient and having moisturizing, cell activation, whitening or antioxidant action. [2] ネマガリダケを有効成分とする保湿剤。  [2] A moisturizing agent containing Negararidake as an active ingredient. [3] ネマガリダケを有効成分とする細胞賦活剤。 [3] A cell activator comprising Negararidake as an active ingredient. [4] ネマガリダケを有効成分とする美白剤。 [4] Whitening agent containing Negararidake as an active ingredient. [5] ネマガリダケを有効成分とする抗酸化剤。 [5] Antioxidant containing Negararidake as an active ingredient.
PCT/JP2006/315612 2006-08-07 2006-08-07 Composition containing nemagaritake and moisturizing agent, cellular stimulant, whitening agent and antioxidant Ceased WO2008018118A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2008528670A JP5014343B2 (en) 2006-08-07 2006-08-07 Nemagaridake-containing composition, moisturizer, cell activator, whitening agent and antioxidant
PCT/JP2006/315612 WO2008018118A1 (en) 2006-08-07 2006-08-07 Composition containing nemagaritake and moisturizing agent, cellular stimulant, whitening agent and antioxidant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2006/315612 WO2008018118A1 (en) 2006-08-07 2006-08-07 Composition containing nemagaritake and moisturizing agent, cellular stimulant, whitening agent and antioxidant

Publications (1)

Publication Number Publication Date
WO2008018118A1 true WO2008018118A1 (en) 2008-02-14

Family

ID=39032663

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/315612 Ceased WO2008018118A1 (en) 2006-08-07 2006-08-07 Composition containing nemagaritake and moisturizing agent, cellular stimulant, whitening agent and antioxidant

Country Status (2)

Country Link
JP (1) JP5014343B2 (en)
WO (1) WO2008018118A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010018530A (en) * 2008-07-09 2010-01-28 Nihon Haruma Kk Method of extracting tyrosinase inhibition activator using apple secondary residue or sasa kurilensis as raw material and its typrosinase inhibition activator
JP2015113291A (en) * 2013-12-10 2015-06-22 共栄化学工業株式会社 Skin cosmetic
JP2019038766A (en) * 2017-08-24 2019-03-14 佐藤 隆 Sebum production promoter
WO2022185819A1 (en) * 2021-03-02 2022-09-09 ライオン株式会社 Skin cleaning agent composition

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5888303A (en) * 1981-11-19 1983-05-26 Shiseido Co Ltd Cosmetic
JPH09249550A (en) * 1996-03-18 1997-09-22 Shiseido Co Ltd Skin preparation for external use
JP2000247864A (en) * 1999-03-01 2000-09-12 Rasheru Seiyaku Kk Cosmetic composition
JP2002128632A (en) * 2000-10-26 2002-05-09 Kyoei Kagaku Kogyo Kk Cosmetic
JP2003231613A (en) * 2002-02-06 2003-08-19 Kameda Seika Co Ltd Whitening cosmetics
JP2004161621A (en) * 2002-11-11 2004-06-10 Pola Chem Ind Inc Keratinizing enzyme inhibitor and skin care preparation for external use comprising the same
JP2004196731A (en) * 2002-12-20 2004-07-15 Pola Chem Ind Inc Cosmetic for depilation
JP2004224750A (en) * 2003-01-24 2004-08-12 Haba Laboratories Inc Serum
JP2004269489A (en) * 2002-05-28 2004-09-30 Haba Laboratories Inc Cosmetic and method for producing the same
JP2004359698A (en) * 2002-05-28 2004-12-24 Haba Laboratories Inc Manufacturing method of cosmetics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001261570A (en) * 2000-03-22 2001-09-26 Nisshin Oil Mills Ltd:The Skin care preparation
WO2001072265A1 (en) * 2000-03-31 2001-10-04 The Nisshin Oil Mills, Ltd. External preparation for the skin and beautifying agents
JP2002212052A (en) * 2001-01-15 2002-07-31 Hajime Ito External preparation
JP2002226386A (en) * 2001-01-30 2002-08-14 Rohto Pharmaceut Co Ltd Composition for integument containing plant extract
JP2004284988A (en) * 2003-03-24 2004-10-14 Kose Corp Hair cosmetic and method for inhibiting carbonylation of hair protein

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5888303A (en) * 1981-11-19 1983-05-26 Shiseido Co Ltd Cosmetic
JPH09249550A (en) * 1996-03-18 1997-09-22 Shiseido Co Ltd Skin preparation for external use
JP2000247864A (en) * 1999-03-01 2000-09-12 Rasheru Seiyaku Kk Cosmetic composition
JP2002128632A (en) * 2000-10-26 2002-05-09 Kyoei Kagaku Kogyo Kk Cosmetic
JP2003231613A (en) * 2002-02-06 2003-08-19 Kameda Seika Co Ltd Whitening cosmetics
JP2004269489A (en) * 2002-05-28 2004-09-30 Haba Laboratories Inc Cosmetic and method for producing the same
JP2004359698A (en) * 2002-05-28 2004-12-24 Haba Laboratories Inc Manufacturing method of cosmetics
JP2004161621A (en) * 2002-11-11 2004-06-10 Pola Chem Ind Inc Keratinizing enzyme inhibitor and skin care preparation for external use comprising the same
JP2004196731A (en) * 2002-12-20 2004-07-15 Pola Chem Ind Inc Cosmetic for depilation
JP2004224750A (en) * 2003-01-24 2004-08-12 Haba Laboratories Inc Serum

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010018530A (en) * 2008-07-09 2010-01-28 Nihon Haruma Kk Method of extracting tyrosinase inhibition activator using apple secondary residue or sasa kurilensis as raw material and its typrosinase inhibition activator
JP2015113291A (en) * 2013-12-10 2015-06-22 共栄化学工業株式会社 Skin cosmetic
JP2019038766A (en) * 2017-08-24 2019-03-14 佐藤 隆 Sebum production promoter
JP7041913B2 (en) 2017-08-24 2022-03-25 隆 佐藤 Sebum production promoter
WO2022185819A1 (en) * 2021-03-02 2022-09-09 ライオン株式会社 Skin cleaning agent composition
JP2022133728A (en) * 2021-03-02 2022-09-14 ライオン株式会社 skin cleanser composition
JP7736408B2 (en) 2021-03-02 2025-09-09 ライオン株式会社 Liquid skin cleanser composition

Also Published As

Publication number Publication date
JP5014343B2 (en) 2012-08-29
JPWO2008018118A1 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
JP4921754B2 (en) Melanin production promoter and neutral fat accumulation inhibitor
JP5014343B2 (en) Nemagaridake-containing composition, moisturizer, cell activator, whitening agent and antioxidant
JP5465037B2 (en) Anti-aging agent, antioxidant, whitening agent, immunostimulant, external preparation for skin and functional oral composition
JP5557414B2 (en) Moisturizer, cell activator, and whitening agent
JP4201091B1 (en) Moisturizer, anti-aging agent, antioxidant and external preparation for skin
JP5062980B2 (en) Moisturizer, collagen production promoter, whitening agent, antioxidant, and vascular endothelial growth factor production promoter
JP4748962B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP4334956B2 (en) Cell activators, whitening agents, and antioxidants
JP2011246375A (en) Whitening agent, antioxidant, skin external preparation, and functional oral composition
JP5550929B2 (en) Moisturizer, anti-aging agent, antioxidant, whitening agent, anti-inflammatory agent, topical skin preparation and functional oral composition
JP4050727B2 (en) Moisturizer, cell activator, whitening agent, antioxidant, and skin external preparation
JP4480366B2 (en) Cell activator, whitening agent, hyaluronic acid production promoter, collagen production promoter, antioxidant, and skin external preparation
JP4994684B2 (en) Moisturizer, cell activator, and antioxidant
JP4970442B2 (en) Whitening agent
JP4291647B2 (en) Cell activator, whitening agent, collagen production promoter, antioxidant, and skin external preparation
JP4931452B2 (en) Moisturizer, cell activator, whitening agent, and antioxidant
JP4869638B2 (en) Cell activator, whitening agent, antioxidant, amylase inhibitor, and humectant
JP5202180B2 (en) Moisturizer, immunostimulant, anti-aging agent, whitening agent, antioxidant, slimming agent, external preparation for skin and functional oral composition
JP4916150B2 (en) Moisturizer, cell activator, antioxidant, and skin external preparation,
JP5383384B2 (en) Anti-aging agent, antioxidant, whitening agent, and immunostimulant
JP2011225477A (en) Anti-aging agent, antioxidant, external preparation for skin, and functional oral composition
JP2013147438A (en) cAMP PRODUCTION INHIBITOR
JP2008074730A (en) Moisturizer, anti-aging agent, whitening agent, anti-inflammatory agent, and antioxidant
JP2011168559A (en) Antioxidant, anti-inflammatory agent, anti-aging agent, skin care preparation for external use and functional oral composition
WO2008035691A1 (en) Moisturizing agent, cell-activating agent, skin-whitening agent, and antioxidant agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06782454

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008528670

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06782454

Country of ref document: EP

Kind code of ref document: A1